News & Coverage

Invitae Acquiring Good Start Genetics and CombiMatrix, Adding Comprehensive Reproductive Health Capabilities to Serve Every Stage of Life

July 31, 2017

Good Start Genetics Deepens Relationship with Amazon offering a First of its Kind Online Ashkenazi Jewish Carrier Screening Test

May 11, 2017

Company Expands Carrier Screening Access to Mass Markets to Better Inform Expectant Parents


Leading Family Genomics Company Good Start Genetics Expands Payor Relationships to More than 130 Million Covered Lives

March 22, 2017

Payor Expansion, Roche Partnership and Recent ACOG Guideline Update, Position Good Start for Rapid Growth


Good Start Genetics and Genome Medical Announce Partnership to Provide Genetic Counseling to Couples Undergoing Carrier Testing

January 11, 2017

Partnership Establishes Strong Foundation as Good Start Builds Additional Momentum Toward Democratization of Genetic Testing


Good Start Genetics Announces Marketing Agreement with Roche Diagnostics for Carrier Screening in the United States

December 5, 2016

Collaboration Marries Good Start’s Proprietary Technology with Roche Diagnostics’ Commercial Expertise for Broad Market Reach


Good Start Genetics Brings First Next-Generation Sequencing (NGS) Test to Amazon Enabling Broad Access to Carrier Screening for Couples Starting a Family

November 2, 2016

Company Establishes Direct Relationship with Largest Online Retailer to Democratize Genetic Testing


Good Start Genetics to Present New Scientific Findings at The American Society of Human Genetics Conference

October 18, 2016

Research Findings Cover HBB/HBA1/HBA2 Gene Testing, SMA Gene Testing, and PGS Segmental Validation Testing


Good Start Genetics Introduces Most Affordable Preimplantation Genetic Screening (PGS) Test on the Market, Broadening Access for More Couples Planning a Family

October 17, 2016

Consistent with its Mission to Democratize Genetic Testing, Company embarks on Simplified Pricing Model of $150 Per Embryo


Good Start Genetics to Present New In Vitro Fertilization Scientific Findings at the American Society of Reproductive Medicine Conference

October 14, 2016

Research Findings Cover Next-Generation Sequencing Technology’s Ability to Detect Embryo Abnormalities


Good Start Genetics Announces New Tier of Offerings Making Genetic Testing More Accessible for Couples Planning a Family

October 13, 2016

At Price Points under $150 for Next-Generation Sequencing (NGS), Company Delivers on Mission to Democratize Genomics


Good Start Genetics Announces Addition to its Executive Team in Preparation for Expansion into Broader Markets

August 16, 2016

Company Appoints James Frontero, Chief Commercial Officer


With Pediatric Scientific Advisory Board, Good Start Genetics Plots a Course to Expanded Markets in Family Care

August 3, 2016

Good Start Genetics Announces Newest Launch of Next-Generation Embryo Screening Product

May 25, 2016

Proprietary Offering Brings Greater Affordability for Best-in-Class Technology for Fertility Populations Globally


Good Start Genetics Appoints Chief Executive Officer

April 6, 2016

Life sciences industry veteran Jeffrey Luber named president and CEO.


Good Start Genetics’ Cost Effectiveness Study Demonstrates Clinical Outcomes and Healthcare Cost Advantages

January 30, 2016

Helix Expands Ecosystem for Consumer Genomics Through Two New Partnerships

January 11, 2016

Good Start Genetics Appoints Chief Financial Officer

January 7, 2016

Seasoned financial executive, Marc Jones, added to company’s leadership team.


Good Start Genetics’ NGS Technologies Detect Up to 30 Percent More Carriers than Traditional Methods

October 20, 2015

Clinical experience using next-generation sequencing shows higher detection rates across more ethnicities when screening for cystic fibrosis, other diseases.


Good Start Genetics Establishes National Relationship with UnitedHealthcare

October 13, 2015

Relationship expands UnitedHealthcare plan participants’ access to lab services.


Good Start Genetics Announces EmbryVu

September 29, 2015

Good Start Genetics, Inc. announced today the availability of EmbryVu, a new preimplantation genetic screening test.


Good Start Genetics Publishes Variant Database Validation Study

June 8, 2015

Good Start Genetics®, Inc. today announced the publication of a study demonstrating its robust variant database validation process. In the paper, the authors confirm that Good Start Genetics’ next generation sequencing (NGS) represents a comprehensive, clinically proven method to screen entire genes, and is thereby able to detect a much larger set of sequence variants across ethnic groups.


Good Start Genetics Reports New Data Reinforcing the Accuracy and Clinical Utility of *GoodStart Select™* Genetic Carrier Screening Technologies

May 5, 2015

Good Start Genetics® presented data from two studies analyzing detection rates among patients at in vitro fertilization (IVF) clinics who underwent carrier screening for inherited diseases.


Good Start Genetics Enters Exclusive License Agreement with Johns Hopkins University for Noninvasive Prenatal Testing (NIPT)

April 13, 2015

Proprietary Technology to Enable Simpler Workflows and Decreased Costs for the Detection of Fetal Chromosomal Abnormalities from a Maternal Blood Sample.